Alpha-1 antitrypsin (Kamada)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAlpha-1 antitrypsin (Kamada)
Drug Alias NameAATA1ATalpha-1-proteinase inhibitorAlpha-1-AntiproteinaseAlpha-1 Antitrypsin +[15] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionSerine protease inhibitors
TargetsSerine protease
Therapy Area/IndicationsRejection of lung transplantationGraft vs Host DiseaseDiabetes Mellitus, Type 1 +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[9] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesKamada
China Registration ClassN/A

Develop Information

Active CompaniesKamadaTuteurKamada Ltd
Inactive CompaniesBaxalta IncorporatedNational Cancer InstituteAmerican Friends Of Rabin Medical Center Inc +[4] 
Active Indicationsalpha 1-Antitrypsin Deficiency
Inactive IndicationsRejection of lung transplantationGraft vs Host DiseaseDiabetes Mellitus, Type 1 +[5] 

Other Information

ATC CodeB02AB02
Related LinksWikipedia